Company / Current Assets
TELA Bio, Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$75.6M
FY2025
5-year range
$59.1M / $78.1M
FY2021-FY2025
Trend
-3.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 7 years, ranging from $59M in FY2021 to $83M in FY2020.
Based on SEC 10-K filings.
$76M in FY2025 with a 5-year CAGR of -1.9%.
Improved from $72M to $76M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +6.6%
- 5-Year CAGR
- -1.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -1.9%, indicating a declining trend.
- In FY2025, current assets decreased 3.2% year-over-year.
- Peak current assets was recorded in FY2020.
- Lowest current assets in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $75.6M | -3.2% |
| FY2024 | $78.1M | +8.8% |
| FY2023 | $71.7M | +14.9% |
| FY2022 | $62.4M | +5.7% |
| FY2021 | $59.1M | -29.0% |
| FY2020 | $83.2M | +29.4% |
| FY2019 | $64.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026